subject area of
- A Multimaterial Microphysiological Platform Enabled by Rapid Casting of Elastic Microwires Academic Article
- AMP-activated protein kinase: the current landscape for drug development Academic Article
- Challenges in the prevention or treatment of RSV with emerging new agents in children from low- and middle-income countries Academic Article
- Current models of pulmonary fibrosis for future drug discovery efforts Academic Article
- Emerging therapeutic targets for idiopathic pulmonary fibrosis: preclinical progress and therapeutic implications Academic Article
- Estimating the clinical cost of drug development for orphan versus non-orphan drugs Academic Article
- Ethics of controlled human infection to address COVID-19 Academic Article
- Model‐Informed Drug Development for Anti‐Infectives: State of the Art and Future Academic Article
- Pediatric drug data in Canadian drug monographs: a descriptive analysis Academic Article
- Regional Approaches to Expedited Drug Development and Review: Can Regulatory Harmonization Improve Outcomes? Academic Article
- Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in Oncology Academic Article
- Synthesis of α-methylstilbenes using an aqueous Wittig methodology and application toward the development of potent human aromatase inhibitors Academic Article
- The Therapeutic Pipeline for Pseudomonas aeruginosa Infections Academic Article
- The challenge of antimicrobial resistance: What economics can contribute Academic Article
- Therapeutic Strategies and Drug Development for Vascular Cognitive Impairment Academic Article
- Therapeutic targets and early stage clinical trials for pulmonary fibrosis Academic Article
- Third human challenge trial conference, Oxford, United Kingdom, February 6–7, 2020, a meeting report Academic Article
- What have we learned from basic science studies on idiopathic pulmonary fibrosis? Academic Article